Company Uses Intravenous Stem Cells to Successfully Treat Alzheimer’s

Company Uses Intravenous Stem Cells to Successfully Treat Alzheimer’s

Stem Cells For Alzheimer'sAn intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells (itMSCs) in a pre-clinical animal model of Alzheimer's disease has been successfully performed by Stemedica International, a subsidiary of Stemedica Cell Technologies, developing stem cell therapies for Alzheimer's disease and dementia.

The first results of the experiment were presented at the Alzheimer

Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *